InsiderFlow

Mark Elliott Boulding

PTCT

Mark Elliott Boulding serves as officer: EXEC. VP AND CLO at PTC Therapeutics, Inc. (PTCT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

32 trades

$22.70M

Net Position

Net Seller

$22.70M

Companies Traded

1

PTCT

Active Period

Jul 2021 – Apr 2026

32 total trades

Most Recent

Sell PTCT

Apr 8, 2026 · $157.3K

Mark Elliott Boulding's Insider Trading at PTC Therapeutics, Inc. (PTCT)

Buys

0 · $0.00

Sells

32 · $22.70M

Total Shares Bought

0

Total Shares Sold

414,126

PTCT Price Chart
Loading chart...
DateTypeValue
Apr 8, 2026 Sell$157.3K
Feb 19, 2026 Sell$209.8K
Feb 17, 2026 Sell$408.6K
Jan 12, 2026 Sell$489.1K
Jan 8, 2026 Sell$511.6K
Jan 6, 2026 Sell$171.2K
Nov 19, 2025 Sell$213.7K
Oct 9, 2025 Sell$214.1K
Oct 7, 2025 Sell$1.64M
Sep 15, 2025 Sell$2.89M
Aug 19, 2025 Sell$136.7K
May 19, 2025 Sell$129.7K
Mar 14, 2025 Sell$827.2K
Mar 12, 2025 Sell$4.00M
Feb 21, 2025 Sell$147.7K
Jan 10, 2025 Sell$158.9K
Dec 4, 2024 Sell$5.02M
Feb 1, 2024 Sell$21.6K
Jan 10, 2024 Sell$98.0K
Apr 19, 2023 Sell$3.18M
Feb 2, 2023 Sell$37.0K
Jan 12, 2023 Sell$47.3K
Jan 11, 2023 Sell$34.8K
Oct 19, 2022 Sell$379.6K
Sep 22, 2022 Sell$64.7K
Apr 15, 2022 Sell$102.8K
Apr 7, 2022 Sell$225.00
Feb 11, 2022 Sell$807.6K
Feb 3, 2022 Sell$31.2K
Jan 11, 2022 Sell$34.1K
Sep 3, 2021 Sell$151.4K
Jul 12, 2021 Sell$372.0K